Cost of products sold, excluding amortization of intangible assets
Breakdown
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Medical Devices | $1.60B | $1.76B | $1.77B | -$12.10B | $1.81B |
| Diagnostic Products | $1.15B | $1.22B | $1.29B | -$8.65B | $1.24B |
| Nutritional Products | $1.12B | $1.16B | $1.22B | -$8.07B | $1.09B |
| Established Pharmaceuticals | $569.00M | $631.00M | $714.00M | -$4.53B | $644.00M |
| Total | $4.47B | $4.85B | $5.08B | $4.92B | $4.89B |
Segments
Established PharmaceuticalsView metric
Nutritional ProductsView metric
Diagnostic ProductsView metric
Medical DevicesView metric